The effect of levetiracetam, an antiseizure therapy, on high-frequency oscillation in patients with Alzheimer’s disease as ...

Shorvon et al. [20] conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and tolerability of levetiracetam as add-on therapy in patients with ...

The drug is the first non-cannabinoid option for patients with LGS and an alternative to Jazz Pharma's Epidyolex (cannabidiol ...

Though phenytoin (PHT) is still the most commonly used agent, levetiracetam (LEV) is increasingly administered for this purpose. This retrospective study compared the use of LEV and PHT as ...

According to DelveInsight’s analysis, the epilepsy market is expected to grow due to an increase in disease prevalence and the expected launch of emerging therapies such as Xenon Pharmaceutical’s ...

High-frequency oscillations in Alzheimer’s may signal seizure risk. Levetiracetam has opposing effects in epileptic and ...

New research identifies high-frequency oscillations as potential biomarkers in Alzheimer’s disease, revealing levetiracetam’s differential effects on epileptic and non-epileptic patients.

A research team from UCLA Health has identified changes in brain rhythms that signal seizure activity in Alzheimer’s patients ...

They found that people who had been prescribed these drugs more frequently, or who took multiple types, had a higher risk of ...